Cost effectiveness of new breast cancer radiotherapy technologies in diverse populations

Breast Cancer Research and Treatment

Volumn 136, Issue 1, 2012, Pages 221-229

  Gold, Heather Taffet ^a   Hayes, Mary Katherine ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Accelerated partial breast radiotherapy; Cost effectiveness analysis; Whole breast radiotherapy

Indexed keywords

ESTROGEN RECEPTOR;

ACCELERATED PARTIAL BREAST RADIOTHERAPY; ARTICLE; BRACHYTHERAPY; BREAST CANCER; CANCER RADIOTHERAPY; CANCER SIZE; COHORT ANALYSIS; COMPUTER ASSISTED RADIOTHERAPY; COST EFFECTIVENESS ANALYSIS; EXTERNAL BEAM RADIOTHERAPY; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; OUTCOME ASSESSMENT; PARTIAL BODY RADIATION; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; RECURRENCE RISK; SENSITIVITY ANALYSIS; STATISTICAL MODEL; THERAPY DELAY; THREE DIMENSIONAL COMPUTER ASSISTED RADIOTHERAPY; WHOLE BREAST RADIOTHERAPY;

BREAST NEOPLASMS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84867868715     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2242-y     Document Type: Article

References (60)

1. American Cancer Society (2008). Cancer facts and figures. American Cancer Society 2008. www.cancer.org. Accessed 14 July 2008
2. Fisher B, Dignam J, Wolmark N, Mamounas E, Costantino J, Poller W et al (1998) Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16(2):441-452
3. Fisher B, Anderson S, Bryant J, Margolese R, Deutsch M, Fisher ER et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347(16):1233-1241
4. Bijker N, Meijnen P, Peterse J, Bogaerts J, Van HI, Julien J et al (2006) Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24(21):3381-3387
5. Whelan TJ, MacKenzie R, Julian J, Levine M, Shelley W, Grimard L et al (2002) Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 94(15):1143-1150
6. Lazovich D, Solomon CC, Thomas DB, Moe RE, White E (1999) Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma. Cancer 86(4):628-637
7. Gold HT, Dick AW (2004) Variations in treatment for ductal carcinoma in situ in elderly women. Med Care 42(3):267-275
8. Baxter NN, Virnig BA, Durham SB, Tuttle TM (2004) Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst 96(6):443-448
9. Nattinger AB, Hoffmann RG, Kneusel RT, Schapira MM (2000) Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast-conserving surgery. Lancet 356(9236):1148-1153
10. Malin JL, Schuster MA, Kahn K, Brook RH (2002) Quality of breast cancer care: what do we know? J Clin Oncol 20(21):4293-4381
11. Gold HT, Do HT, Dick AW (2008) Correlates and effect of suboptimal radiotherapy in women with ductal carcinoma in situ or early invasive breast cancer. Cancer 113(11):3108-3115
12. Gold HT, Thwin SS, Buist DS, Field TS, Ulcickas Yood M, Lash TL et al (2009) Delayed radiotherapy for breast cancer patients in integrated delivery systems. Am J Manag Care 15(11):785-789
13. Nattinger AB, Kneusel RT, Hoffmann RG, Gilligan MA (2001) Relationship of distance from a radiotherapy facility and initial breast cancer treatment. J Natl Cancer Inst 93(17):1344-1346
14. Athas WF, Adams-Cameron M, Hunt WC, Amir-Fazli A, Key CR (2000) Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst 92(3):269-271
15. Schroen AT, Brenin DR, Kelly MD, Knaus WA, Slingluff CL Jr (2005) Impact of patient distance to radiation therapy on mastectomy use in early-stage breast cancer patients. J Clin Oncol 23(28):7074-7080
16. Rose CM, Recht A (2003) Accelerated partial-breast irradiation (APBI): let's give it a good test. Int J Radiat Oncol Biol Phys 57(5):1217-1218
17. Benitez PR, Keisch ME, Vicini F, Stolier A, Scroggins T, Walker A et al (2007) Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg 194(4):456-462
18. Veronesi U, Marubini E, Mariani L, Galimberti V, Luini A, Veronesi P et al (2001) Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 12(7):997-1003
19. Clark RM, Whelan T, Levine M, Roberts R, Willan A, McCulloch P et al (1996) Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst 88(22):1659-1664
20. Holli K, Saaristo R, Isola J, Joensuu H, Hakama M (2001) Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized study. Br J Cancer 84(2):164-169
21. Liljegren G, Holmberg L, Bergh J, Lindgren A, Tabar L, Nordgren H et al (1999) 10-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol 17(8):2326-2333
22. Fisher ER, Dignam J, Tan-Chiu E, Costantino J, Fisher B, Paik S et al (1999) Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 86(3):429-438
23. Sanders ME, Scroggins T, Ampil FL, Li BD (2007) Accelerated partial breast irradiation in early-stage breast cancer. J Clin Oncol 25(8):996-1002
24. National Surgical Adjuvant Breast and Bowel Project, Radiation Therapy Oncology Group (2005). NSABP PROTOCOL B-39/RTOG PROTOCOL 0413: a randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, Or II breast cancer. http://clinicaltrials.gov/ct2/show/NCT00103181. Accessed 13 March 2007
25. Dowlatshahi K, Snider HC, Gittleman MA, Nguyen C, Vigneri PM, Franklin RL (2004) Early experience with balloon brachytherapy for breast cancer. Arch Surg 139(6):603-608
26. Vicini F, Beitsch PD, Quiet CA, Keleher AJ, Garcia D, Snider HC Jr et al (2008) Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI). Cancer 112(4):758-766
27. Ott OJ (2008). Clinical trial: interstitial brachytherapy alone versus external beam radiation therapy after breast conserving surgery for low risk invasive carcinoma and low risk duct carcinoma in situ (DCIS) of the female breast. http://www.apbi.uni-erlangen.de/outline/outline.html. Accessed 09 May 2012
28. Ontario Clinical Oncology Group (2006). Clinical trial: NCT00282035: RAPID: randomized trial of accelerated partial breast irradiation. http://clinicaltrials.gov/ct2/. Accessed 09 May 2012
29. Polgar C, Sulyok Z, Fodor J, Orosz Z, Major T, Takacsi-Nagy Z et al (2002) Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: five-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol 80(3):121-128
30. Benitez PR, Streeter O, Vicini F, Mehta V, Quiet C, Kuske R et al (2006) Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study. Am J Surg 192(4):427-433
31. Blue Cross Blue Shield Association (2007) Accelerated partial breast irradiation as sole radiotherapy after breast-conserving surgery for early stage breast cancer. Report no. 22(4). Blue Cross and Blue Shield Association, Chicago, IL
32. Smith GL, Xu Y, Buchholz TA, Smith BD, Giordano SH, Haffty BG et al (2011) Brachytherapy for accelerated partial-breast irradiation: a rapidly emerging technology in breast cancer care. J Clin Oncol 29(2):157-165
33. Suh WW, Pierce LJ, Vicini FA, Hayman JA (2005) A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast cancer. Int J Radiat Oncol Biol Phys 62(3):790-796
34. Sher DJ, Wittenberg E, Suh WW, Taghian AG, Punglia RS (2009) Partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer: a cost-effectiveness analysis. Int J Radiat Oncol Biol Phys 74(2):440-446
35. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366(9503):2087-2106
36. Fisher B, Wickerham DL, Deutsch M, Anderson S, Redmond C, Fisher ER (1992) Breast tumor recurrence following lumpectomy with and without breast irradiation: an overview of recent NSABP findings. Semin Surg Oncol 8(3):153-160
37. Wickerham DL, Anderson SA, Fisher B, Margolese R, Mamounas T, Wolmark N (1998) NSABP Protocol B-06: a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancerresults after 15 years of follow-up. Eur J Cancer 34(Supplement 5):36-38
38. Gold MR, Siegel JE, Russell LB, Weinstein MC (1996) Cost-effectiveness in health and medicine. Oxford University Press, New York
39. Braithwaite RS, Meltzer DO, King JT Jr, Leslie D, Roberts MS (2008) What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule? Med Care 46(4):349-356
40. Early Breast Cancer Trialists' Collaborative Group (2002) Tamoxifen for early breast cancer. Cochrane Database Syst Rev 4: CD000486
41. Forbes JF, Cuzick J, Buzdar A, Howell A, Tobias JS, Baum M (2008) Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol 9(1):45-53
42. Abner AL, Recht A, Eberlein T, Come S, Shulman L, Hayes D et al (1993) Prognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early-stage breast cancer. J Clin Oncol 11(1):44-48
43. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ et al (2008) SEER cancer statistics review, 1975-2005. National Cancer Institute, Bethesda
44. Krauss DJ, Kestin LL, Mitchell C, Martinez AA, Vicini FA (2004) Changes in temporal patterns of local failure after breast-conserving therapy and their prognostic implications. Int J Radiat Oncol Biol Phys 60(3):731-740
45. Arias E (2007) United States life tables, 2004. Natl Vital Stat Rep 2856(9):1-40
46. Hayman JA, Fairclough DL, Harris JR, Weeks JC (1997) Patient preferences concerning the trade-off between the risks and benefits of routine radiation therapy after conservative surgery for early-stage breast cancer. J Clin Oncol 15(3):1252-1260
47. Lee JH, Glick HA, Hayman JA, Solin LJ (2002) Decision-analytic model and cost-effectiveness evaluation of postmastectomy radiation therapy in high-risk premenopausal breast cancer patients. J Clin Oncol 20(11):2713-2725
48. Sher DJ, Wittenberg E, Taghian AG, Bellon JR, Punglia RS (2008) Partial breast irradiation versus whole breast radiotherapy for early-stage breast cancer: a decision analysis. Int J Radiat Oncol Biol Phys 70(2):469-476
49. Alderman AK, Hawley ST, Morrow M, Salem B, Hamilton A, Graff JJ et al (2011) Receipt of delayed breast reconstruction after mastectomy: do women revisit the decision? Ann Surg Oncol 18(6):1748-1756
50. Barlow W, Taplin S, Yoshida CK, Buist DS, Seger D, Brown M (2001) Cost comparison of mastectomy versus breast-conserving therapy for early-stage breast cancer. J Natl Cancer Inst 93(6):447-455
51. Hayman JA, Hillner BE, Harris JR, Pierce LJ, Weeks JC (2000) Cost-effectiveness of adding an electron-beam boost to tangential radiation therapy in patients with negative margins after conservative surgery for early-stage breast cancer. J Clin Oncol 18(2):287-295
52. Bureau of Labor Statistics UDoL (2009) Bureau of Labor Statistics consumer price index inflation calculator. http://www.bls.gov/data/inflation- calculator.htm2010. Accessed 2 Jan 2009
53. Adjuvant! Online (2009) Decision making tools for health care professionals. www.adjuvantonline.com. Accessed 14 Oct 2009
54. Ravdin PM, Siminoff LA, Davis GJ, Mercer MB, Hewlett J, Gerson N et al (2001) Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol 19(4):980-991
55. Smith TE, Lee D, Turner BC, Carter D, Haffty BG (2000) True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys 48(5):1281-1289
56. Nelson AL, Cohen JT, Greenberg D, Kent DM (2009) Much cheaper, almost as good: decrementally cost-effective medical innovation. Ann Intern Med 151(9):662-667
57. Vicini FA, Beitsch PD, Quiet CA, Keleher A, Garcia D, Snider HC et al (2005) First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial. Cancer 104(6):1138-1148
58. Food and Drug Administration (2009). MAUDE adverse event reports. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs. Accessed 09 May 2012
59. Fisher B, Dignam J, Bryant J, DeCillis A, Wickerham DL, Wolmark N et al (1996) Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst 88(21):1529-1542
60. Yabroff KR, Davis WW, Lamont EB, Fahey A, Topor M, Brown ML et al (2007) Patient time costs associated with cancer care. J Natl Cancer Inst 99(1):14-23